Hi Aria, yes. I haven't sold my shares. The company is going through governance changes so it's quiet while they conduct their search. Board is quiet too. I'm patiently waiting to hear news on that but definitely looking forward to hearing an update on their clinical programs, particularly MD Anderson program. Maybe they will just sell the company. That likely is the easiest way to capitalize on their checkpoint inhibitors, sell to big Pharma. Seems no one shareholders are really selling. Just a few trades here and there. So I'm waiting. :)
News 
Market Data 
Discover 
